Nonemissive Ruthenium Complexes for Near Infrared-II Photodynamic, Photothermal, Sonodynamic, and Sonothermal Therapy Against Drug-Resistant Cancer
Journal of Medicinal Chemistry · 28.08.2025 · 68 (16) · 17653-17666
DOI: 10.1021/acs.jmedchem.5c01371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 04.08.2025. Verfasst von Ran Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Provincial Center for Research & Development of Natural Pro…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Coordination Complexes, Lung Neoplasms, Photosensitizing Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Yunnan Provincial Science and Technology Department, Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nine nonemissive Ru(II) complexes have been designed for synergistic NIR-II (1064 nm) photodynamic, photothermal, sonodynamic, and sonothermal therapy targeting cisplatin-resistant nonsmall cell lung cancer. Their quantum yields of singlet oxygen and superoxide anions are significantly elevated under low-power NIR-II laser irradiation or ultrasound treatment. The selected complex RY7 completely eradicated drug-resistant lung cancer tumors in all tested mice when treated simultaneously with NIR-II laser and ultrasound at a minimal drug dosage in vivo and was promptly eliminated from the organism. The application of a single-molecule sensitizer to achieve synergistic NIR-II photodynamic/photothermal/sonodynamic/sonothermal therapy may provide important insights into the treatment of deeply located tumors, tackling tumor hypoxia and addressing the complicated pharmacological mechanisms underlying drug resistance. The two-photon absorption quantum chemical calculations presented in this study may also serve as a powerful tool for the rational design and structure–activity relationship studies of two-photon photosensitizers and optical materials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Provincial Center for Research & Development of Natural Products; School of Pharmacy, Yunnan University, Kunming 650500, P. R. Ch…
- Animal Research and Resource Center, School of Life Sciences, Yunnan University, Kunming 650500, P. R. China.
ORCID-Profile: Jingbo Chen, Feng Gao
Förderung
- Yunnan Provincial Science and Technology Department
- Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province
- National Natural Science Foundation of China
Zitieren
APA
Song, R., Zhao, R. Y., Yan, R., Li, X. L., Zeng, L. Z., Cai, Z., Chen, J., Ren, X., Cheng, X., & Gao, F. (2025). Nonemissive Ruthenium Complexes for Near Infrared-II Photodynamic, Photothermal, Sonodynamic, and Sonothermal Therapy Against Drug-Resistant Cancer. Journal of Medicinal Chemistry, 68(16), 17653-17666. https://doi.org/10.1021/acs.jmedchem.5c01371
Vancouver
Song R, Zhao RY, Yan R, Li XL, Zeng LZ, Cai Z, et al. Nonemissive Ruthenium Complexes for Near Infrared-II Photodynamic, Photothermal, Sonodynamic, and Sonothermal Therapy Against Drug-Resistant Cancer. Journal of Medicinal Chemistry. 2025;68(16):17653-17666. doi:10.1021/acs.jmedchem.5c01371
BibTeX
@article{Song2025,
author = {Song, Ran and Zhao, Run-Yu and Yan, Ru and Li, Xue-Lian and Zeng, Li-Zhen and Cai, Zhongyan and Chen, Jingbo and Ren, Xiaoxia and Cheng, Xiaohong and Gao, Feng},
title = {Nonemissive Ruthenium Complexes for Near Infrared-II Photodynamic, Photothermal, Sonodynamic, and Sonothermal Therapy Against Drug-Resistant Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {16},
pages = {17653--17666},
doi = {10.1021/acs.jmedchem.5c01371}
}
EUVIMED